anti-Lipocalin 2 (LCN2) Antikörper

anti-Lipocalin 2 Antikörper (LCN2)
Auf finden Sie aktuell 477 Lipocalin 2 (LCN2) Antikörper von 31 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen Lipocalin 2 Kits (145) und Lipocalin 2 Proteine (73) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 715 Lipocalin 2 Produkte verfügbar.
24p3, AW212229, LCN2, MSFI, NGAL, Sip24

Meistgesuchte Reaktivitäten zu anti-Lipocalin 2 (LCN2) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human Antikörper:

anti-Mouse (Murine) Antikörper:

anti-Rat (Rattus) Antikörper:

Alle verfügbaren anti-Lipocalin 2 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-Lipocalin 2 Antikörper

  1. Human Polyclonal LCN2 Primary Antibody für IHC, IHC (p) - ABIN4331126 : Rathore, Berard, Redensek, Chierzi, Lopez-Vales, Santos, Akira, David: Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 (PubMed)
    Zeige alle 3 Referenzen für 4331126

  2. Human Polyclonal LCN2 Primary Antibody für IHC (p), IHC - ABIN250360 : Yu, Wu, Ping, Huang, Shen: NGAL can alternately mediate sunitinib resistance in renal cell carcinoma. in The Journal of urology 2014 (PubMed)
    Zeige alle 2 Referenzen für 250360

  3. Human Polyclonal LCN2 Primary Antibody für IF (p), IHC (p) - ABIN685627 : Xing, Wang, Cheng, Montaner, Mandeville, Leung, van Leyen, Lok, Wang, Lo: Neuronal production of lipocalin-2 as a help-me signal for glial activation. in Stroke; a journal of cerebral circulation 2014 (PubMed)
    Zeige alle 2 Referenzen für 685627

  4. Mouse (Murine) Polyclonal LCN2 Primary Antibody für ELISA, WB - ABIN408671 : Venkatesha, Hanai, Seth, Karumanchi, Sukhatme: Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells. in Molecular cancer research : MCR 2006 (PubMed)

  5. Human Polyclonal LCN2 Primary Antibody für IHC, ELISA - ABIN185405 : Mishra, Dent, Tarabishi, Mitsnefes, Ma, Kelly, Ruff, Zahedi, Shao, Bean, Mori, Barasch, Devarajan: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. in Lancet 2005 (PubMed)

Weitere Antikörper gegen Lipocalin 2 Interaktionspartner

Human Lipocalin 2 (LCN2) Interaktionspartner

  1. Data suggest that elevated serum LCN2 level in overweight/obese women may serve as biomarker for risk of developing metabolic syndrome (MetS (zeige ETV3 Antikörper)); serum NGAL levels positively correlated with saturated fatty acid dietary intake; serum NGAL increased proportionally with increase in MetS (zeige ETV3 Antikörper) risk factors. This study was conducted in the Republic of Korea.

  2. The role of LCN2 in Iron Homeostasis and Inflammation is reviewed.

  3. The results indicate that urine levels of NGAL and retinol binding protein may be independently associated with albuminuria in the diagnosis of type 2 diabetic nephropathy and may serve as novel biomarkers for the identification of type 2 diabetic nephropathy.

  4. clinical significance of serum levels of neutrophil gelatinase-associated lipocalin (sNGAL) as a biomarker for predicting in-hospital outcomes in patients with ST-elevated myocardial infarction (STEMI)

  5. Serum and urinary NGAL were higher in the critically ill group that developed acute kidney injury compared to critically ill patients without AKI.

  6. LCN-2 expression and serum levels could discriminate IGT from NGT and type 2 diabetes mellitus (T2DM)from IGT obese women and early predicting T2DM among obese women. While, LCN-2 expression level was the independent predictor of IGT in obese women. Combination of both LCN-2 expression and serum levels improved their diagnostic value in early detection of IGT and T2DM among obese women

  7. LCN2 modulated the secretion of proinflammatory cytokines in PSC of the PDAC tumor microenvironment, whereas downregulation of LCN2-specific receptor SLC22A17 (zeige SLC22A17 Antikörper) blocked these effects. Our results reveal how LCN2 acts in the tumor microenvironment links obesity, inflammation, and PDAC development.

  8. Both in our animal model and in human Age-related macular degeneration (AMD (zeige AMD1 Antikörper)), the AKT2 (zeige AKT2 Antikörper)-NF-kappaB (zeige NFKB1 Antikörper)-LCN-2 signalling axis is involved in activating the inflammatory response.

  9. Data suggget that urine neutrophil gelatinase-associated lipocalin (NGAL) may be helpful for detecting inflammation and selecting mesenchymal stem cell (MSC (zeige MSC Antikörper)) transplantation timing in ischemia-reperfusion (I/R) kidney injury.

  10. effect of lipocalin 2 on thrombotic events in polycythemia vera (zeige IGF2BP3 Antikörper) and essential thrombocythemia patients

Mouse (Murine) Lipocalin 2 (LCN2) Interaktionspartner

  1. Results suggest that blood brain barrier leakage occurs in white matter after subarachnoid hemorrhage (SAH (zeige ACSM3 Antikörper)) and that LCN2 contributes to SAH (zeige ACSM3 Antikörper)-induced blood brain barrier disruption.

  2. LCN2 overexpression in bones modifies the bone marrow microenvironment via modulation of the expression of key secreted factors and cytokines, which in turn regulate the hematopoietic stem cell niche behavior enhancing both HSC (zeige FUT1 Antikörper) homing in young mice and erythrocytes production in older mice.

  3. LCN2 modulated the secretion of proinflammatory cytokines in PSC of the PDAC tumor microenvironment, whereas downregulation of LCN2-specific receptor SLC22A17 (zeige SLC22A17 Antikörper) blocked these effects. Our results reveal how LCN2 acts in the tumor microenvironment links obesity, inflammation, and PDAC development.

  4. results identify lipocalin 2 as a bone-derived hormone with metabolic regulatory effects, which suppresses appetite in a MC4R (zeige MC4R Antikörper)-dependent manner, and show that the control of appetite is an endocrine function of bone

  5. Lcn2 can suppress the beneficial cardiac autophagic response to ischemia and that this contributes to enhanced ischemia-induced cell death and cardiac dysfunction.

  6. Plasma levels of LCN2 measured in patients one week after ischemic stroke contribute to the prediction of clinical outcome at 90 days and reflect the systemic response to post-stroke infections

  7. may potentiate the development of psoriasis via the enhancement of Th17- and antimicrobial peptide (zeige cAMP Antikörper)-mediated inflammation

  8. The acute stress protein LCN2, produced from RPE (zeige RPE Antikörper) cells and the neural retina, could modulate retinal inflammation and retinal homeostasis; therefore, such families of proteins could contribute to cell survival during retinal insults.

  9. Stroma-secreted Lcn2 promotes metastasis in vitro and in vivo, thereby contributing to tumor progression.

  10. study demonstrated a pivotal and causal role of LCN2 in the development of alcoholic fatty liver disease

Pig (Porcine) Lipocalin 2 (LCN2) Interaktionspartner

  1. we demonstrated the presence of high molecular weight (HMW) complexes (130, 170, and 220 kDa) containing MMP9 (zeige MMP9 Antikörper), TIMP1 (zeige TIMP1 Antikörper), and NGAL (also MMP2 (zeige MMP2 Antikörper) in 220 kDa complex) without proteolytic activity.

  2. porcine p25alpha (zeige Tppp Antikörper) is heavily modified with a variety of modifications: phosphorylation, di- and trimethylation, citrullination and a HexNAc group.

Lipocalin 2 (LCN2) Antigen-Profil

Beschreibung des Gens

mouse homolog plays a role in IL3 withdrawal-induced apoptosis

Alternative names and synonyms associated with Lipocalin 2 (LCN2)

  • lipocalin 2 (LCN2) Antikörper
  • lipocalin 2 (Lcn2) Antikörper
  • lipocalin 2-like (LOC100352980) Antikörper
  • 24p3 Antikörper
  • AW212229 Antikörper
  • LCN2 Antikörper
  • MSFI Antikörper
  • NGAL Antikörper
  • Sip24 Antikörper

Bezeichner auf Proteinebene für anti-Lipocalin 2 (LCN2) Antikörper

lipocalin 2 , lipocalin 2 (oncogene 24p3) , 25 kDa alpha-2-microglobulin-related subunit of MMP-9 , lipocalin-2 , migration-stimulating factor inhibitor , neutrophil gelatinase-associated lipocalin , oncogene 24p3 , p25 , siderocalin LCN2 , SV-40-induced 24P3 protein , secreted inducible protein 24 , NGAL , alpha-2-microglobulin-related protein , alpha-2U globulin-related protein

464764 Pan troglodytes
697208 Macaca mulatta
3934 Homo sapiens
16819 Mus musculus
170496 Rattus norvegicus
100153501 Sus scrofa
491320 Canis lupus familiaris
101121411 Ovis aries
526639 Bos taurus
100352980 Oryctolagus cuniculus
Ausgewählte Anbieter für anti-Lipocalin 2 (LCN2) Antikörper
Haben Sie etwas anderes gesucht?